Talk:United Aerospace Command/@comment-24142455-20150712135122

-Report to UAC Department of Technology-

The UAC will begin the development on flash cloning, a medical process most commonly used to clone body parts. Cells used during cloning must be taken from specific regions within the body. The process can be used to create organs, skin, blood, or other body parts needed by recipients in a short span of time. This allows the creation of blood cells for use in blood transfusions, or the manufacturing of nerve cells to repair certain types of paralysis.

Flash cloning will replaced donated organs as the standard means of organ replacement for both civilian and military purposes. Organs such as the heart, liver, or the endocrine system will be able to be replaced with cloned parts, which can be used to negate the effects of an unhealthy lifestyle and to extend the lifespan of a human being by decades.

The process uses a sample of a human's DNA to grow a cloned organ, which can then be transplanted into the subject who contributed the DNA sample. Usually the organ is programmed to grow at an accelerated rate and cease rapid development when transplanted into the subject. This makes the method viable in urgent situations, where patients cannot afford to spend years waiting for a normal organ to develop. Since the transplanted organ's DNA matches that of the recipient, the risk of transplant rejection is completely eliminated.

However, flash cloning will not be possible on a scale of a human being, and cloning a human being is already illegal by the standards of the UAC Genetics Rights Act. Rapid flash cloning of such immense volumes of tissue induces gross DNA base-pair errors; congenital defects increase 42 percent and incidents of Parkinson's-plus syndromes increase 67 percent. Although a small percentage of flash clones can have a normal life expectancy, most flash clones will start to degenerate from metabolic instability as part of a process called "metabolic cascade failure"—death from various neurological and physiological disorders and the lack of an immune system. The assumed average half-life of a flash clone if created would be 14.7 weeks in laboratory conditions

The goal of flash cloning is to allow a more effective way to save lives, and eliminate the use of organ donors. Research time will be 3 weeks.

-Dr. Catherine Halsey